OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-Drug Antibodies in Patients with Inflammatory Bowel Diseases Treated with Biosimilar Infliximab: A Prospective Cohort Study
Anna Pękala, Rafał Filip, David Aebisher
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2653-2653
Open Access | Times Cited: 6
Anna Pękala, Rafał Filip, David Aebisher
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2653-2653
Open Access | Times Cited: 6
Showing 6 citing articles:
Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease
Min Seob Kwak, Jae Myung, Jung Won Jeon, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 2, pp. 36-36
Open Access | Times Cited: 6
Min Seob Kwak, Jae Myung, Jung Won Jeon, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 2, pp. 36-36
Open Access | Times Cited: 6
Personalizing therapy selection in inflammatory bowel disease
Arushi Kohli, Alan C. Moss
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Arushi Kohli, Alan C. Moss
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
Guanglin Cui, Jon Florholmen, Rasmus Goll
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Guanglin Cui, Jon Florholmen, Rasmus Goll
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
An exploratory analysis of glucagon‐like peptide‐1 (GLP ‐1) agonists and biosimilars: A literature review
Jimmy Wen, Adam A Razick, Christiane How‐Volkman, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access
Jimmy Wen, Adam A Razick, Christiane How‐Volkman, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access
Levels of Biosimilar Infliximab during and after Induction Treatment in Crohn’s Disease and Ulcerative Colitis—A Prospective Polish Population Study
Anna Pękala, Rafał Filip
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5311-5311
Open Access | Times Cited: 1
Anna Pękala, Rafał Filip
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5311-5311
Open Access | Times Cited: 1
Monitoring of infliximab treatment in inflammatory bowel diseases – basic knowledge and current data based on clinical trials in a population of Polish patients
Anna Pękala
European Journal of Clinical and Experimental Medicine (2022) Vol. 20, Iss. 3, pp. 251-259
Open Access
Anna Pękala
European Journal of Clinical and Experimental Medicine (2022) Vol. 20, Iss. 3, pp. 251-259
Open Access
